Abstract Library
Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.
Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.
ENETS Abstract Search
Introduction: The carcinoid heart is present in approximately 20% of cases at the diagnosis of carcinoid dyndrome in neuroendocrine tumors, and will occur in approximately 50% of patients during follow-up. The consequence is the appearance of stenosing and/or leaking valvular diseases, responsible, eventually, right or left ventricular dysfunction and severe heart failure. Only surgical valve replacement treatment seems to be able to improve the prognosis, but at the cost of significant perioperative morbidity and mortality.
Conference:
Presenting Author: Kaid M
Authors: Kaid M, Bengueddach A, Bennaoum A, Kehili H, Bereksi-Reguig F,
Keywords: carcinoid heart disease, somatostatin,
#3738 Breast neuroendocrine carcinoma – A case report
Introduction: Neuroendocrine breast tumors are a rare entity estimated at 0.1% of all breast tumors.
Conference:
Presenting Author:
Authors: Kaid M, Bengueddache A, Kehili H, Bennaoum A, Bereksi-Reguig F,
Keywords: breast neuroendocrine tumor,
#3311 Clinical management of neuroendocrine neoplasms (NENs) in the time of COVID-19
Introduction: The current SARS-CoV-2 virus epidemic is an exceptional global health situation, very serious for already fragile patients such as cancer patients. These patients are at much higher risk (4 to5 times) of severe respiratory complications, which develop very quickly, especially since they will have received surgery or chemotherapy in the preceding weeks, putting their vital prognosis at risk, in addition to the risk of cancer «double jeopardy».
Conference: 18th Annual ENETS Concerence (2021)
Presenting Author:
Authors: Bengueddach A, Kehili H, Kaid M, Bereksi Reguig F, Tidjene A,
Keywords: COVID-19, SARS-CoV-2, neuroendocrine,
Introduction: The current recommendations for management of neuroendocrine tumor diseases are still evolving, due to the limited experience on this issue. As the new coronavirus can be transmitted through breath droplets, by contact, there is no consensus of how this fact may affect the investigation and treatment of neuroendocrine tumor diseases.
Conference: 18th Annual ENETS Concerence (2021)
Presenting Author:
Authors: Bengueddach A, Kaid M, Kehili H, Tidjene A, Bereksi Reguig F,
Keywords: neuroendocrine, covid-19, treatment,
Introduction: Most small bowel neuroendocrine tumours (SBNET) are Grade 1 (G1), and exhibit at least nodal metastasis at diagnosis. The clinical behaviours of G1 SBNET remain poorly predictable. The ‘NET nomogram’ developed by Modlin et al. designates SBNET as low/medium/high risk by mathematical analysis of 15 clinicopathological parameters.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: Clift A